Published on
Today, the United States House Energy and Commerce Subcommittee on Health will host a hearing titled “Innovation Saves Lives: Evaluating Medicare Coverage Pathways for Innovative Drugs, Medical Devices, and Technology." The National Down Syndrome Society (NDSS) submitted a statement for the record addressing the impact that Medicare coverage pathways for innovative drugs has on individuals with Down syndrome, specifically as it relates to Alzheimer’s disease and related dementia. Click to read NDSS's statement below.
Document
